Article Details

Resilience keeps expansion spree rolling with buyout of biologics maker Ology

Retrieved on: 2021-04-13 14:08:39

Tags for this article:

Click the tags to see associated articles and topics

Resilience keeps expansion spree rolling with buyout of biologics maker Ology. View article details on hiswai:

Excerpt

... and vectors, oncolytic viruses, plasmids and monoclonal antibodies. When it comes to antibodies, Ology isn't sticking to manufacturing alone.

Article found on: www.fiercepharma.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo